July 6, 2020 Gilead Sciences has announced that the European Commission has granted conditional marketing authorization for Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing authorization was granted in the interest of public…
Jun 18, 2020 The U.S. Food and Drug Administration has issued warning letters to four companies for selling unapproved injectable drug products labeled as homeopathic that can pose serious risks to patient health and violate federal law, as part of…
Jun 17, 2020 Dexamethasone, a low cost corticosteroid available in tablet as well as injectable form has become the first drug to show survival improvement in critically ill cornoavirus patients. As per the study conducted in UK, Researchers found that…
Jun 16, 2020 The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19…
May 21, 2020 Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.…
Recent Post
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India
- Navigating Drug Rules in India: A Guide for Pharmaceutical Marketers